FRAMINGHAM, Mass.--(EON: Enhanced Online News)--A new webinar series for the pharmaceutical industry is underway to tackle some of the biggest challenges in drug discovery and development across biologics and small molecule analysis.
“As a trusted partner with pharmaceutical and biopharmaceutical companies all over the world, we are committed to our goal to deliver relevant content on what matters to them. That’s why the pharma industry continues to partner with AB SCIEX.”
Anyone who is interested in bioanalysis, biologics, lipid analysis, metabolite ID or related pharmaceutical applications can access the online presentations free of charge from anywhere by clicking here. All live webinars are held at 11 a.m. Eastern / 8 a.m. Pacific on the dates specified on the event page on absciex.com.
“The AB SCIEX Pharma & Biologics Webinar Series is intended to give pharma and biopharma scientists the opportunity to gain new insight from top scientists driving significant advancements in capability, productivity and cost savings,” said Joe Fox, Senior Director of Pharma and Biologics at AB SCIEX. “As a trusted partner with pharmaceutical and biopharmaceutical companies all over the world, we are committed to our goal to deliver relevant content on what matters to them. That’s why the pharma industry continues to partner with AB SCIEX.”
Topics in the webinar series include:
- Challenges and practical solutions in large molecule quantification
- Optimizing high-throughput LC/MS/MS bioanalysis in drug discovery
- High-throughput data independent approach for qualitative and quantitative lipidomic analysis
- High-throughput metabolite identification
- Combining sensitivity and selectivity for targeted peptide quantitation
- SWATH-based pharmacokinetic quantification to increase selectivity, specificity and signal-to-noise ratio with benefits of non-targeted approach
For the complete line-up of speakers and topics, please go to:
AB SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to push the limits in their field and address the complex analytical challenges they face. The company’s global leadership and world-class service and support in the mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With more than 40 years of proven innovation, AB SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information about the company, go to www.absciex.com. Follow AB SCIEX on Twitter @ABSCIEX, Facebook and LinkedIn.
© 2013. AB SCIEX. Unless otherwise noted in our product literature, AB SCIEX Products Are For Research Use Only. Not for use in Diagnostics Procedures. For more information, refer to www.absciex.com/products. The trademarks mentioned herein are the property of AB Sciex Pte. Ltd. or their respective owners. AB SCIEXTM is being used under license.